Psychedelic Assisted Therapy mini-series
Part 3: PSILOCYBIN-ASSISTED THERAPY: HISTORY, BASIC SCIENCE, NEUROPHYSIOLOGY, CLINICAL APPLICATIONS, AND THE OVERLAP WITH SPIRITUALITY, MEDITATION, AND TRANCE
Presenters: Dr. Charles Grob, MD | Dr. David Presti, Ph.D. | Dr. Rael Cahn, MD, Ph.D.
Date: Thursday, April 20th, 12 - 2 pm PST
CME Credits: 2 Credits
This two-hour presentation will explore psilocybin-assisted therapy's growing scientific terrain and integral nature. Each speaker will present for approximately 30 minutes with dedicated moderation to allow for an integrated community discussion, including questions and answers for the speakers.
Part 2: Ketamine-Assisted Therapy in Psychiatry: Spiritual, Group, and Meditative Frameworks Potentiating Clinical Benefits
Presenters: Scott Shannon, M.D. // Elias Dakwar, M.D. // Rael Cahn, M.D., Ph.D.
Dr. Rael Cahn will moderate and lead a discussion between the attendees, Scott and Elias regarding the respective role of spirituality, group dynamics, and mindfulness in mediating the clinical efficacy of ketamine-assisted therapy.
Part 1: An overview of MDMA-assisted therapy for PTSD
Presenters: Allison Coker, Ph.D. // Dimitri Perivoliotis, Ph.D. // Shannon Carlin, M.A., L.M.F.T.
Researchers talk about the evidence base supporting MDMA-assisted therapy for PTSD, the mechanisms behind it, and the elements behind the MAPS PBC MDMA-assisted therapy for PTSD treatment protocol.